Health

Bezos-Buffett-Dimon health care plan will be a ‘very difficult effort’

The joint foray by Amazon, J.P. Morgan along with also Berkshire Hathaway into health care isn’t the newest idea, the idea’s just the most recent, CVS Health’s chairman says. The three corporate giants’ announcement they would likely create a not-for-profit company aimed at cutting their health-care costs along with also improving services sparked panic on Wall Street for what the ...

Read More »

Sports medicine tech gives US Olympic skiers, snowboarders an edge

Lindsey Vonn remains one of the most gifted along with decorated downhill skiers ever, along with at age 33 she’s poised to expand upon her greatness at the XXIII Winter Olympic Games in Pyeongchang, South Korea. Yet her snowy paths to glory have been cratered with spectacular crashes along with horrible injuries — broken bones, torn ligaments, concussions — which ...

Read More »

Flu kills 10 more children, bringing toll to 63 kids

David Goldman | AP Reed Olson, 8, gets a flu shot at a Dekalb County health center in Decatur, Ga., Monday, Feb. 5, 2018. one more 10 children have died of flu from the U.S., bringing the total to 63 in a harsh season which is actually still going strong, federal health officials said Friday. The flu was still widespread ...

Read More »

Harvard genetics pioneer will monetize DNA with digital currency

Users of 23andMe receive a testing kit before agreeing to share their DNA for research purposes. When registering the kit online, 23andMe provides a separate consent form in addition to explains to users in which in which won’t share personal DNA information without “explicit consent.” A majority of users do consent to share their DNA information for research purposes, as ...

Read More »

Jeff Immelt looks for redemption as chair of $5 billion Athenahealth

Jeff Immelt, former CEO of global conglomerate General Electric, brings star power along having a wealth of experience to his brand-new role as chairman of the maturing health-care firm Athenahealth, analysts say. However, Wall Street also sees Immelt’s move as a chance for redemption, after his departure coming from GE within the latter half of 2017 capped a rocky 16-year ...

Read More »

Many people take dangerously high amounts of ibuprofen

Many adults who use ibuprofen in addition to some other so-called nonsteroidal anti-inflammatory (NSAID) drugs take too much, increasing their risk of serious side effects like internal bleeding in addition to heart attacks, a U.S. study suggests. About 15 percent of adults taking ibuprofen (Motrin, Advil) or some other NSAIDs like aspirin, naproxen (Aleve), celecoxib (Celebrex), meloxicam (Mobic) in addition ...

Read More »

CVS hikes wages along with also announces Q4 earnings

CVS Health will increase employee pay along with also sweeten benefits to some employees using a portion of the company’s windfall through the completely new tax law. CVS will boost starting pay for hourly employees to $11 per hour through $9 per hour, starting in April. Pay ranges along with also rates will be adjusted for many of its retail ...

Read More »

CVS still expects Aetna deal to close inside second half of the year

CVS Health still expects its $69 billion acquisition of Aetna to close inside second half of the year despite the Department of Justice’s request for more information. The two want to create an integrated health system of which combines pharmacy in addition to health benefits while delivering preventive care services through the drugstore chain’s retail clinics. Last week, the DOJ ...

Read More »

Teva warns on 2018 profits citing US market, Copaxone

Teva Pharmaceutical on Thursday said 2018 results might be weaker than expected due to difficult conditions inside U.S. generics market as well as fierce competition facing its branded multiple sclerosis drug. Israel-based Teva, the earth’s largest generic drugmaker, will be facing cost erosion, increased competition as well as a consolidating customer base, particularly inside United States. the idea also carries ...

Read More »

Teva chief reports ‘strong progress’ in restructuring plan

The chief executive of Teva Pharmaceuticals says he will be doing “strong progress” on the company’s restructuring plan, although has acknowledged the generic drug giant faces a challenging 2018. Kare Schultz, Teva’s brand new CEO, provided the update as the company released its fourth-quarter earnings Thursday. Teva in December announced plans to cut 14,000 jobs, roughly one-quarter of its work ...

Read More »